Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) FCF Margin (2018 - 2025)

Dna X filings provide 8 years of FCF Margin readings, the most recent being 43.38% for Q3 2025.

  • On a quarterly basis, FCF Margin fell 3969.0% to 43.38% in Q3 2025 year-over-year; TTM through Sep 2025 was 50.34%, a 4108.0% decrease, with the full-year FY2024 number at 17.09%, down 1272.0% from a year prior.
  • FCF Margin hit 43.38% in Q3 2025 for Dna X, up from 43.63% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 6.37% in Q2 2022 to a low of 110.41% in Q4 2021.
  • Median FCF Margin over the past 5 years was 29.79% (2024), compared with a mean of 31.04%.
  • Biggest five-year swings in FCF Margin: plummeted -8044bps in 2021 and later surged 10119bps in 2022.
  • Dna X's FCF Margin stood at 110.41% in 2021, then skyrocketed by 92bps to 9.23% in 2022, then surged by 71bps to 2.7% in 2023, then crashed by -2097bps to 59.4% in 2024, then grew by 27bps to 43.38% in 2025.
  • The last three reported values for FCF Margin were 43.38% (Q3 2025), 43.63% (Q2 2025), and 57.45% (Q1 2025) per Business Quant data.